Cargando…
Causes of Renal Allograft Injury in Recipients With Normal Donor-derived Cell-free DNA
BACKGROUND. Donor-derived cell-free DNA (dd-cfDNA) is a noninvasive biomarker for the early detection of organ transplant rejection and other causes of graft injury. For nonrejection renal injuries, there is little information about the performance characteristics of this biomarker. We highlight som...
Autores principales: | Xie, Wen Yan, Kim, Kevin, Goussous, Naeem, Drachenberg, Cinthia B., Scalea, Joseph R., Weir, Matthew R., Bromberg, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935401/ https://www.ncbi.nlm.nih.gov/pubmed/33688578 http://dx.doi.org/10.1097/TXD.0000000000001135 |
Ejemplares similares
-
Donor-derived Cell-free DNA in Infections in Kidney Transplant Recipients: Case Series
por: Goussous, Naeem, et al.
Publicado: (2020) -
Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study
por: Wali, Ravinder K., et al.
Publicado: (2016) -
Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018) -
Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016) -
Procurement Biopsy Findings Versus Kidney Donor Risk Index for Predicting Renal Allograft Survival
por: Hall, Isaac E., et al.
Publicado: (2018)